Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
COVID-19
Vanessa Romo, NPR

FDA approves first rapid COVID-19 test

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

The Food and Drug Administration has approved the first rapid point-of-care COVID-19 test, that can deliver results in less than an hour.

Cepheid, a Silicon Valley diagnostics company, made the announcement on Saturday, saying it has received emergency authorization from the government to use the test.

While the agency has approved about a dozen other COVID-19 tests in response to the public health emergency caused by the coronavirus pandemic, this is the first one that can be used at the point of care.

Cepheid said the test kits will be available by the end of the month.

Until now, to get test result, a health care worker would take a swab from the back of a person's nose, and send it off to a public health, commercial or hospital lab, or to a lab at the Centers for Disease Control and Prevention in Atlanta. The process can take days.

The newly approved test kit still involves taking a nasal swab, but the test can be done in a doctor's office or clinic with a detection time of approximately 45 minutes, according to Cepheid.

"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities," said Dr. David Persing, chief medical and technology officer at Cepheid.

He added: "An accurate test delivered close to the patient can be transformative — and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources."

State and local government leaders have been putting pressure on the Trump administration and the coronavirus task force led by Vice President Mike Pence to address widespread testing shortages. In response, the administration has turned to the private sector to help develop tests, vaccines and therapeutic medicines to help stem the pandemic.

On Saturday, Pence confirmed more than 195,000 people have been tested for the respiratory virus. Of those, roughly 19,350 have tested positive for the coronavirus.

Copyright 2020 NPR. To see more, visit https://www.npr.org.